103 related articles for article (PubMed ID: 17973254)
1. Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures.
Leclerc N; Noh T; Cogan J; Samarawickrama DB; Smith E; Frenkel B
J Cell Biochem; 2008 Apr; 103(6):1938-51. PubMed ID: 17973254
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner.
Eijken M; Meijer IM; Westbroek I; Koedam M; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2008 May; 104(2):568-79. PubMed ID: 18186078
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.
Leclerc N; Noh T; Khokhar A; Smith E; Frenkel B
Arthritis Rheum; 2005 Mar; 52(3):929-39. PubMed ID: 15751078
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling inhibits cementoblast differentiation and promotes proliferation.
Nemoto E; Koshikawa Y; Kanaya S; Tsuchiya M; Tamura M; Somerman MJ; Shimauchi H
Bone; 2009 May; 44(5):805-12. PubMed ID: 19442631
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.
Rodda SJ; McMahon AP
Development; 2006 Aug; 133(16):3231-44. PubMed ID: 16854976
[TBL] [Abstract][Full Text] [Related]
6. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization.
Eijken M; Koedam M; van Driel M; Buurman CJ; Pols HA; van Leeuwen JP
Mol Cell Endocrinol; 2006 Mar; 248(1-2):87-93. PubMed ID: 16406260
[TBL] [Abstract][Full Text] [Related]
7. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts.
Vaes BL; Dechering KJ; van Someren EP; Hendriks JM; van de Ven CJ; Feijen A; Mummery CL; Reinders MJ; Olijve W; van Zoelen EJ; Steegenga WT
Bone; 2005 May; 36(5):803-11. PubMed ID: 15820155
[TBL] [Abstract][Full Text] [Related]
8. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
9. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
10. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.
Gordon JA; Tye CE; Sampaio AV; Underhill TM; Hunter GK; Goldberg HA
Bone; 2007 Sep; 41(3):462-73. PubMed ID: 17572166
[TBL] [Abstract][Full Text] [Related]
11. Developmentally regulated inhibition of cell cycle progression by glucocorticoids through repression of cyclin A transcription in primary osteoblast cultures.
Gabet Y; Noh T; Lee C; Frenkel B
J Cell Physiol; 2011 Apr; 226(4):991-8. PubMed ID: 20857405
[TBL] [Abstract][Full Text] [Related]
12. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation.
Li X; Liu P; Liu W; Maye P; Zhang J; Zhang Y; Hurley M; Guo C; Boskey A; Sun L; Harris SE; Rowe DW; Ke HZ; Wu D
Nat Genet; 2005 Sep; 37(9):945-52. PubMed ID: 16056226
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice.
Zhou H; Mak W; Kalak R; Street J; Fong-Yee C; Zheng Y; Dunstan CR; Seibel MJ
Development; 2009 Feb; 136(3):427-36. PubMed ID: 19141672
[TBL] [Abstract][Full Text] [Related]
15. Potential involvement of the interaction between insulin-like growth factor binding protein (IGFBP)-6 and LIM mineralization protein (LMP)-1 in regulating osteoblast differentiation.
Strohbach C; Kleinman S; Linkhart T; Amaar Y; Chen ST; Mohan S; Strong D
J Cell Biochem; 2008 Aug; 104(5):1890-905. PubMed ID: 18395833
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
17. Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells.
Olkku A; Mahonen A
Bone; 2008 Sep; 43(3):483-93. PubMed ID: 18555765
[TBL] [Abstract][Full Text] [Related]
18. Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development.
Gori F; Friedman LG; Demay MB
Dev Biol; 2006 Jul; 295(2):498-506. PubMed ID: 16730692
[TBL] [Abstract][Full Text] [Related]
19. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
Nakano Y; Addison WN; Kaartinen MT
Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.
Ding J; Ghali O; Lencel P; Broux O; Chauveau C; Devedjian JC; Hardouin P; Magne D
Life Sci; 2009 Apr; 84(15-16):499-504. PubMed ID: 19302812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
